GOVX
GeoVax Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.48
−4.68%Aug 28, 2026, 20:32 UTC
GeoVax Labs, Inc. received a notice from Nasdaq on August 27, 2026, stating it no longer complies with the minimum bid price requirement under Rule 5550(a)(2), and plans to request a hearing before the Nasdaq Hearings Panel before the September 3, 2026 deadline.
Aug 28, 2026, 20:21 UTC
GeoVax Labs, Inc. signed an inducement letter on August 25, 2026, under which a holder agreed to exercise existing common stock purchase warrants for cash, in exchange for new warrants to purchase 200% of the exercised shares at $0.64 per share, raising approximately $3,646,482.
May 7, 2026, 00:00 UTC
GeoVax Labs, Inc. entered into a warrant inducement private placement on May 8, 2026, issuing new common stock purchase warrants to existing warrant holders as an inducement for their cash exercise of outstanding warrants for 501,144 shares, raising approximately $595,000 in gross proceeds.